vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $11.5M, roughly 1.9× TRANSACT TECHNOLOGIES INC). TRANSACT TECHNOLOGIES INC produced more free cash flow last quarter ($589.0K vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
AUTL vs TACT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $11.5M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | 47.6% |
| Operating Margin | -337.9% | -10.1% |
| Net Margin | -373.3% | — |
| Revenue YoY | — | 11.9% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $11.5M | ||
| Q3 25 | $21.2M | $13.2M | ||
| Q2 25 | $20.9M | $13.8M | ||
| Q1 25 | $9.0M | $13.1M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $0 | $10.9M | ||
| Q2 24 | $0 | $11.6M | ||
| Q1 24 | $10.1M | $10.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-79.1M | $15.0K | ||
| Q2 25 | $-47.9M | $-143.0K | ||
| Q1 25 | $-70.2M | $19.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $-551.0K | ||
| Q2 24 | $-58.3M | $-319.0K | ||
| Q1 24 | $-52.7M | $-1.0M |
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
| Q4 25 | — | -10.1% | ||
| Q3 25 | -337.9% | 0.1% | ||
| Q2 25 | -292.6% | -1.9% | ||
| Q1 25 | -726.3% | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | — | -7.7% | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | -384.1% | -12.2% |
| Q4 25 | — | — | ||
| Q3 25 | -373.3% | 0.1% | ||
| Q2 25 | -229.0% | -1.0% | ||
| Q1 25 | -781.1% | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | -522.1% | -9.7% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.30 | $0.00 | ||
| Q2 25 | $-0.18 | $-0.01 | ||
| Q1 25 | $-0.26 | $0.00 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-0.31 | $-0.06 | ||
| Q2 24 | $-0.22 | $-0.03 | ||
| Q1 24 | $-0.24 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $31.1M |
| Total Assets | $661.9M | $44.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $20.4M | ||
| Q3 25 | $86.1M | $20.0M | ||
| Q2 25 | $123.8M | $17.7M | ||
| Q1 25 | $95.8M | $14.2M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | $657.1M | $11.3M | ||
| Q2 24 | $705.9M | $11.1M | ||
| Q1 24 | $758.5M | $10.6M |
| Q4 25 | — | $31.1M | ||
| Q3 25 | $265.5M | $31.8M | ||
| Q2 25 | $346.5M | $31.3M | ||
| Q1 25 | $371.1M | $30.9M | ||
| Q4 24 | — | $30.6M | ||
| Q3 24 | $477.0M | $38.4M | ||
| Q2 24 | $527.8M | $38.5M | ||
| Q1 24 | $582.0M | $38.6M |
| Q4 25 | — | $44.8M | ||
| Q3 25 | $661.9M | $45.0M | ||
| Q2 25 | $721.0M | $44.5M | ||
| Q1 25 | $746.3M | $44.2M | ||
| Q4 24 | — | $44.0M | ||
| Q3 24 | $827.5M | $50.5M | ||
| Q2 24 | $853.6M | $50.4M | ||
| Q1 24 | $901.4M | $51.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $609.0K |
| Free Cash FlowOCF − Capex | $-72.3M | $589.0K |
| FCF MarginFCF / Revenue | -341.2% | 5.1% |
| Capex IntensityCapex / Revenue | 20.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $7.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $609.0K | ||
| Q3 25 | $-67.9M | $3.6M | ||
| Q2 25 | $-72.8M | $3.6M | ||
| Q1 25 | $-75.6M | $-161.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $-76.7M | $327.0K | ||
| Q2 24 | $-51.1M | $636.0K | ||
| Q1 24 | $-40.5M | $-1.5M |
| Q4 25 | — | $589.0K | ||
| Q3 25 | $-72.3M | $3.6M | ||
| Q2 25 | $-80.1M | $3.6M | ||
| Q1 25 | $-83.8M | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $-86.3M | $259.0K | ||
| Q2 24 | $-51.9M | $499.0K | ||
| Q1 24 | $-41.0M | $-1.6M |
| Q4 25 | — | 5.1% | ||
| Q3 25 | -341.2% | 27.1% | ||
| Q2 25 | -382.6% | 25.9% | ||
| Q1 25 | -933.1% | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | -406.8% | -14.9% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 20.8% | 0.5% | ||
| Q2 25 | 34.8% | 0.1% | ||
| Q1 25 | 91.8% | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | 5.3% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
